SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Aug 17, 2020
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient population is defined as all adult patients hospitalized in the University Hospital Basel from April 1st, 2020 to June 14th, 2020.
- Exclusion Criteria:
- • Outpatients
- • Patients with SARS-CoV-2 screening in the outpatient test center
- • Patients with a SARS-CoV-2 test more than 72 hours before hospital admission
- • Test not performed (for any reason)
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Sarah Tschudin-Sutter, Prof. Dr. MD
Principal Investigator
University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials